Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience. [electronic resource]

By:

Bupathi, M

Contributor(s):

Ahn, D H
Wu, C
Ciombor, K K
Stephens, J A
Reardon, J
Goldstein, D A
Bekaii-Saab, T

Producer: 20161213Description: 37 p. digitalISSN:

1559-131X

Subject(s):

Adenocarcinoma -- drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Camptothecin -- administration & dosage
Costs and Cost Analysis
Disease-Free Survival
Female
Fluorouracil -- administration & dosage
Humans
Infusions, Intravenous
Irinotecan
Leucovorin -- administration & dosage
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy
Retrospective Studies
Treatment Outcome

Online resources:

Available from publisher's website

In: Medical oncology (Northwood, London, England) vol. 33

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Clinical Trial; Journal Article

There are no comments on this title.

Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience.

APA

Bupathi M., Ahn D. H., Wu C., Ciombor K. K., Stephens J. A., Reardon J., Goldstein D. A. & Bekaii-Saab T. (20161213). Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience. : Medical oncology (Northwood, London, England).

Chicago

Bupathi M, Ahn D H, Wu C, Ciombor K K, Stephens J A, Reardon J, Goldstein D A and Bekaii-Saab T. 20161213. Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience. : Medical oncology (Northwood, London, England).

Harvard

Bupathi M., Ahn D. H., Wu C., Ciombor K. K., Stephens J. A., Reardon J., Goldstein D. A. and Bekaii-Saab T. (20161213). Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience. : Medical oncology (Northwood, London, England).

MLA

Bupathi M, Ahn D H, Wu C, Ciombor K K, Stephens J A, Reardon J, Goldstein D A and Bekaii-Saab T. Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience. : Medical oncology (Northwood, London, England). 20161213.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC